|View printer-friendly version|
|August 14, 2006 1:56 p.m.|
|Teva Announces Launch of Generic Zoloft®|
Jerusalem, Israel, August 14, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has begun the sale of its generic version of Pfizer's Zoloft® (Sertraline) Tablets, 25 mg, 50 mg, and 100 mg in the United States. As the first company to file an ANDA containing a paragraph IV certification for this product, Teva has been awarded a 180-day period of marketing exclusivity.